CTA018

· OPKO IP Holdings II, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CTA018, covering 2014-09-29 to 2014-11-06. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of CTA018 Injection to Treat Stage 5 Chronic Kidney Disease [Phase 2]